Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model

Table 1 Patient population characteristics

	Patients	Death	Liver transplant
n	257	27	25
Gender
Male	136	21	17
Female	121	6	8
Age (yr)
mean ± SE	52.2 ± 0.71	55.9 ± 1.88	52.9 ± 2.1
Body mass index
mean ± SE	30.7 ± 0.45	29.65 ± 1.19	29.11 ± 0.45
Race
White	217	26	24
Black	11	0	0
Asian	7	0	0
Hispanic	4	0	1
Others	18	1	0
Non-BA parameters (mean ± SE)
Creatinine (mg/dL)	1.02 ± 0.09
Albumin (g/dL)	3.53 ± 0.04
INR	1.19 ± 0.02
Protime (s)	12.01 ± 0.42
AST (U/L)	59.9 ± 4.07
ALT (U/L)	54.9 ± 4.26
Bilirubin (mg/dL)	1.75 ± 0.15
AST/ALT	1.28 ± 0.04
MELD	10.6 ± 0.34
APRI	1.15 ± 0.11

BA: Bile acids; INR: International normalized ratio; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; MELD: Model for end-stage liver disease; APRI: Aspartate aminotransferase/platelet ratio index.